中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 4
Apr.  2011

Promoter methylation in APC, RASSF1A, WIF-1 gene in digestive system tumors

Research funding:

 

  • Published Date: 2011-04-20
  • The digestive system tumor is very common amongst human malignant tumors.The recent research indicate that the aberrant promoter methylation plays an important role in the progression of tumor.This review summarizes the role of three suppressor genes APC, RASSF1A and WIF-1 and methylation in the carcinogenesis of digestive system.

     

  • [1]Herman JG, merlo A, Mao Li, et al.Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNAmethylation in all common human cancer[J].Cancer Res, 1995, 55 (20) :4525-4530.
    [2]Rein T, Depamphillis ML, Zorbas H, et al.Identifying5-methylcytosine and related modification in DNA genes[J].Nucleic Acids Res, 1995, 55 (20) :4525-4530.
    [3]Kamiyama H, Noda H, Takata O, et al.Promoter hypermethylation of tumor-related genes in peritoneal lavage and theprognosis of patients with colorectal cancer[J].J Surg Oncol, 2009, 100 (1) :69-74.
    [4]Powell SM, Zilz N, Bryan TM, et al.APC gene mutation occurearly during colorectal tumorigenesis[J].Nature, 1992, 359 (6392) :235-237.
    [5]Homma MK, Li D, Krebs EG, et al.Association and regulationof casein kinase 2 activity by adenomatous polyposis coliprotein[J].Proc Natl Acad Sci U S A, 2002, 99 (9) :5959-5964.
    [6]Yutaka S, Chi WW, Yutaka K, et al.Epigenetic-Genetic Interactionsin the APC/WNT, RAS/RAF, and P53 Pathways in ColorectalCarcinoma[J].Clin Cancer Res 2008, 14 (9) :2560-2569.
    [7]Kumar K, Brin H, Giardiello F, et al.Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadiccolorectal cancer in African Americans[J].Clin Cancer Res, 2009, 15 (4) :1155-1161.
    [8]Tang M, Torres-Lanzas J, Lopez-Rios F, et al.Wnt signalingpromoter hypermethylation distinguishes lung primaryadenocarcinomas from colorectal metastasis to the lung[J].Int J Cancer, 2006, 119 (11) :2603-2606.
    [9]吴龙, 钱叶本, 朱立新, 等.肝细胞癌中SFRP1和APC基因启动子甲基化与其mRNA的表达[J].中国普通外科杂志, 2008, 17 (1) :29-33.
    [10]Kiran M, Chawla YK, Kaur J, et al.Methylation profiling oftumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India[J].CancerGenet Cytogenet, 2009, 195 (2) :112-119.
    [11]Lee HC, Kim M, Wands JR, et al.Wnt/Frizzled signaling inhepatocellular carcinoma[J].Front Biosci, 2006, 11:1901-1915.
    [12]Colnot S, Decaens T, Niwa Kawakita M, et al.Liver-targetedDisruption of Apc in Mice Activates Beta-catenin Signalingand Leads to Hepatocellular Carcinomas[J].Proc Natl AcadSci U S A, 2004, 101 (49) :17216-17221.
    [13]Ksiaa F, Ziadi S, Amara K, et al.Biological significance of promoterhypermethylation of tumor related genes in patients with gastriccarcinoma[J].Clin Chim Acta, 2009, 404 (2) :128-133.
    [14]Lee SH, Kang HJ, Shin DH, et al.Expression of beta-cateninand its mechanism of delocalization in intestinal-typeearly gastric cancer based on mucin expression[J].HistolHistopathol, 2009, 24 (7) :831-838.
    [15]Esteller M, Sparks A, Toyota M, et al.Analysis of adenom-atous polyposis coli promoter hypermethylation in humancancer[J].Cancer Res, 2000, 60 (16) :4366-4371.
    [16]Clement G, Braunschweig R, Pasquier N, et al.Methy-lation of APC, TIMP3, and TERT:a new predictive marker todistinguish Barrett's oesophagus patients at risk for malignanttransformation[J].J Pathol, 2006, 208 (1) :100-107.
    [17]Brock MV, Gou M, Akiyama Y, et al.Prognostic importance ofpromoter hypermethylation of multiple genes in esophagealadenocarcinoma[J].Clin Cancer Res, 2003, 9 (8) :2912-2919.
    [18]丁振, 钱叶本, 熊奇如, 等.肝细胞癌中WIF-1基因启动子甲基化状态及mRNA表达的研究[J].肝胆外科杂志, 2008, 16 (4) :304-307.
    [19]张影, 张福奎, 王宝恩.经典Wnt信号通路与肝脏病的研究进展[J].世界华人消化杂志, 2008, 16 (9) :975-981.
    [20]程勤, 金洁, 于彬, 等.肝癌细胞中WIF-1的甲基化状态分析[J].复旦学报, 2007, 34 (6) :843-847.
    [21]郭艳丽, 郭炜, 靳国梁, 等.贲门腺癌WIF-1基因启动子区甲基化状态的检测及临床意义[J].第三军医大学学报, 2009, 32 (21) :2094-2097.
    [22]Taniguchi H, Yamamoto H, Hirata T, et al.Freque-nt epigeneticinactivation of Wnt inhibitory factor-1 in human gastrointestinalcancers[J].Oncogene, 2005, 11 (53) :7946-7952.
    [23]Lee BB, Lee EJ, Jung EH, et al.Aberrant methylation ofAPC, MGMT, RASSF2A, and Wif-1 genes in plasma as abiomarker for early detection of colorectal cancer[J].ClinCancer Res, 2009, 15 (19) :6185-6191.
    [24]Taniguchi H, Yamaoto H, Hirata T, et al.Frequent epigeneticinactivation of Wnt inhibitory factor-1 in human gastrointestinalcancers[J].Oncogene, 2005, 11 (53) :7946-7952.
    [25]Hu L, Chen G, Yu HP, et al.Clinicopathological significanceof RASSF1A reduced expression and hypermethylation inhepatocellular carcinoma[J].Hepatol Int, 2010, 4 (1) :423-432.
    [26]周晓俊, 薛万江, 秦磊, 等.原发性肝癌中RASSF1A基因表达失活及其临床意义[J].江苏医药, 2007, 33 (1) :24-27.
    [27]Chan KC, Lai PB, Mok TS, et al.Quantitative analysis ofcirculating methylated DNA as a biom arker for hepatocellularcarcinoma[J].Clin Chem, 2008, 54 (9) :1528-1536.
    [28]刘培, 姜相君, 葛银林, 等.RASSF1A基因启动子区甲基化在胃癌组织中的检测[J].世界华人消化杂志, 2009, 17 (30) :3144-3147.
    [29]蒋鹏程, 马圭, 孟鑫, 等.RASSF1A在胃癌中的甲基化检测及表达[J].现代肿瘤医学, 2009, 17 (6) :1115-1118.
    [30]Tamotsu K, Francesco T, Sai Y, et al.Promoter Hype-rmethylation of RASSF1A in Esophageal Squamous CellCarcinoma[J].Clin Cancer Res, 2003, 9 (4) :1441-1445.
    [31]Gonzalo V, Lozano JJ, Balaguer F, et al.Aberrant genepromoter methylation associated with sporadic multiplecolorectal cancer[J].PLoS One, 2010, 5 (1) :e8777.
    [32]Sakamoto LHT, DE Camargo B, Cajaiba M, et al.MT1Ghypermethylation:a potential prognostic marker forhepatoblastoma[J].Pediatr Res, 2010, 67 (4) :387-393.
    [33]Jin Z, Mori Y, Hamilton JP, et al.Hypermethylation of thesomatostatin promoter is a common, early event in humanesophageal carcinogenesis[J].Cancer, 2008, 112:43-49.
    [34]董科, 李波, 覃扬, 等.5-氮杂胞苷抑制肝癌细胞恶性表型和逆转甲基化状态的作用及机制[J].世界华人消化杂志, 2008, 16 (17) :1842-1848.
  • Relative Articles

    [1]Hou YiHui, Liu TengFei, Zhao XiaoQing, Zhang LiaoYun. Effect of different direct-acting antivirals on the clinical outcome of genotype 1b chronic hepatitis C and compensated hepatitis C cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 84-87. doi: 10.3969/j.issn.1001-5256.2020.01.019
    [2]Zhang JieBing, Guo HongHua. Research advances in hepatitis B cirrhosis with renal injury and the application of antiviral drugs[J]. Journal of Clinical Hepatology, 2019, 35(1): 191-196. doi: 10.3969/j.issn.1001-5256.2019.01.042
    [3]Zhang Xi, Li YongGuo. Current status of the application of direct-acting antiviral agents in treatment of chronic hepatitis C and existing problems[J]. Journal of Clinical Hepatology, 2018, 34(4): 853-857. doi: 10.3969/j.issn.1001-5256.2018.04.034
    [4]Ren Shan, Chen XinYue. Current research on hepatitis C virus resistance to direct-acting antiviral agents[J]. Journal of Clinical Hepatology, 2015, 31(11): 1807-1812. doi: 10.3969/j.issn.1001-5256.2015.11.010
    [5]Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430.
    [6]Zhang YanMei, Ding XiaoHui. Anti-viral therapy in adult patients with acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1327-1330+1344.
    [7]Guo XinHui, Yan Yan, Li Zhuo, Yin JiMing. Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 65-67.
    [8]Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64.
    [9]Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290.
    [10]Qin Hua, Wu XiaoQing. Distribution and clinical significance of HBV genotypes in Lanzhou district[J]. Journal of Clinical Hepatology, 2010, 26(3): 295-296.
    [11]Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294.
    [12]Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394.
    [13]Chen Yan, Tian DeYing, Xia NingShao. Epidemiology and the genotypes of HEV isolated from patients with hepatitis E in Wuhan[J]. Journal of Clinical Hepatology, 2006, 22(1): 36-38.
    [14]Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106.
    [15]Liu ChengYong, Hou YuanPei, Qian XiuMei, Sun Qing, Song Li. Distribution of hepatitis B virus genotype in Xuzhou and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(3): 151-152.
    [16]Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18.
    [18]Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159.
    [19]Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76.
    [20]Yao Gang, Zhang Lian, Bao LiHua. HBV genotypes and efficacy of interferon-α on patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(5): 273-274.
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 4.7 %FULLTEXT: 4.7 %META: 93.0 %META: 93.0 %PDF: 2.3 %PDF: 2.3 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 2.8 %其他: 2.8 %其他: 0.2 %其他: 0.2 %China: 0.5 %China: 0.5 %上海: 1.4 %上海: 1.4 %亚特兰大: 0.2 %亚特兰大: 0.2 %北京: 6.3 %北京: 6.3 %北海: 0.2 %北海: 0.2 %南京: 0.2 %南京: 0.2 %南宁: 0.2 %南宁: 0.2 %吉林: 0.5 %吉林: 0.5 %呼和浩特: 1.4 %呼和浩特: 1.4 %哥伦布: 0.2 %哥伦布: 0.2 %宿迁: 0.5 %宿迁: 0.5 %崇左: 0.5 %崇左: 0.5 %常州: 0.2 %常州: 0.2 %广州: 0.2 %广州: 0.2 %张家口: 3.1 %张家口: 3.1 %成都: 0.7 %成都: 0.7 %新乡: 2.1 %新乡: 2.1 %昆明: 0.5 %昆明: 0.5 %杭州: 0.7 %杭州: 0.7 %武汉: 0.5 %武汉: 0.5 %淄博: 0.2 %淄博: 0.2 %淮安: 0.2 %淮安: 0.2 %深圳: 1.4 %深圳: 1.4 %玉林: 1.9 %玉林: 1.9 %石家庄: 1.2 %石家庄: 1.2 %芒廷维尤: 32.9 %芒廷维尤: 32.9 %芝加哥: 0.2 %芝加哥: 0.2 %苏州: 0.2 %苏州: 0.2 %莫斯科: 1.6 %莫斯科: 1.6 %西宁: 29.8 %西宁: 29.8 %贵港: 0.9 %贵港: 0.9 %连云港: 0.2 %连云港: 0.2 %郑州: 5.2 %郑州: 5.2 %长春: 0.7 %长春: 0.7 %其他其他China上海亚特兰大北京北海南京南宁吉林呼和浩特哥伦布宿迁崇左常州广州张家口成都新乡昆明杭州武汉淄博淮安深圳玉林石家庄芒廷维尤芝加哥苏州莫斯科西宁贵港连云港郑州长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (4668) PDF downloads(920) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return